These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32703665)

  • 1. Hyperhemolytic Transfusion Reaction in Non-Hemoglobinopathy Patients and Terminal Complement Pathway Activation: Case Series and Review of the Literature.
    Cid J; Fernández J; Palomo M; Blasco M; Bailó N; Diaz-Ricart M; Lozano M
    Transfus Med Rev; 2020 Jul; 34(3):172-177. PubMed ID: 32703665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review.
    Win N; Sinha S; Lee E; Mills W
    Transfus Med Rev; 2010 Jan; 24(1):64-7. PubMed ID: 19962576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of macrophage marker in hyperhaemolytic transfusion reaction: a case report.
    Win N; Lee E; Needs M; Chia LW; Stasi R
    Transfus Med; 2012 Apr; 22(2):137-41. PubMed ID: 22233101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction.
    Roumenina LT; Bartolucci P; Pirenne F
    Transfus Med Rev; 2019 Oct; 33(4):225-230. PubMed ID: 31672341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent hyperhemolytic transfusion reaction in myelodysplastic syndrome- A case based approach.
    Augustine M; Murugesan M; Nair CK; Raghavan V; Nayanar SK
    Transfus Apher Sci; 2021 Jun; 60(3):103073. PubMed ID: 33581999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhemolytic Syndrome Complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 Alloimmunization, in a Pregnant Woman with HbO-Arab/β-Thalassemia.
    Bezirgiannidou Z; Christoforidou A; Kontekaki E; Anastasiadis AG; Papamichos SI; Menexidou H; Margaritis D; Martinis G; Mantadakis E
    Mediterr J Hematol Infect Dis; 2016; 8(1):e2016053. PubMed ID: 27872733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human erythrocytes (CHUHE) assay.
    Cunnion KM; Hair PS; Krishna NK; Whitley PH; Goldberg CL; Fadeyi EA; Maes LY
    Transfusion; 2016 Jul; 56(7):1845-8. PubMed ID: 26997226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-N and anti-Do
    Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
    Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions.
    Merle NS; Boudhabhay I; Leon J; Fremeaux-Bacchi V; Roumenina LT
    Transfus Clin Biol; 2019 May; 26(2):116-124. PubMed ID: 30879901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
    Uhlmann EJ; Shenoy S; Goodnough LT
    Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of A plasma for incompatible patients.
    Olsen G; Passwater M; Huggins M; Mukhtar F; Pelletier P
    Transfusion; 2021 Feb; 61(2):375-378. PubMed ID: 33219552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
    Beck TN; Young NG; Erickson ML; Prats I
    BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell transfusion in patients with anti-Yt
    Wong SM; Cawthorne T; Dennington PM; Hong FS
    Transfusion; 2021 Feb; 61(2):379-384. PubMed ID: 33410173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
    Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS
    Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and mechanisms of antibody-mediated hemolysis.
    Flegel WA
    Transfusion; 2015 Jul; 55 Suppl 2(0):S47-58. PubMed ID: 26174897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion.
    Weinstock C; Möhle R; Dorn C; Weisel K; Höchsmann B; Schrezenmeier H; Kanz L
    Transfusion; 2015 Mar; 55(3):605-10. PubMed ID: 25251967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed hemolytic transfusion reaction in children with sickle cell disease.
    de Montalembert M; Dumont MD; Heilbronner C; Brousse V; Charrara O; Pellegrino B; Piguet C; Soussan V; Noizat-Pirenne F
    Haematologica; 2011 Jun; 96(6):801-7. PubMed ID: 21330322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhemolytic transfusion reaction in sickle cell disease.
    Win N; Doughty H; Telfer P; Wild BJ; Pearson TC
    Transfusion; 2001 Mar; 41(3):323-8. PubMed ID: 11274584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.
    Vlachaki E; Gavriilaki E; Kafantari K; Adamidou D; Tsitsikas D; Chasapopoulou E; Anagnostopoulos A; Tsapas A
    Hemoglobin; 2018; 42(5-6):339-341. PubMed ID: 30626228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.
    Galbusera M; Noris M; Gastoldi S; Bresin E; Mele C; Breno M; Cuccarolo P; Alberti M; Valoti E; Piras R; Donadelli R; Vivarelli M; Murer L; Pecoraro C; Ferrari E; Perna A; Benigni A; Portalupi V; Remuzzi G
    Am J Kidney Dis; 2019 Jul; 74(1):56-72. PubMed ID: 30851964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.